Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIP Trial: Vincristine or Cisplatin with Gemcitabine or Pemetrexed in Advanced NSCLC in Elderly Patients
2012-005504-17Phase 2Completed
- Sponsor
- Institute of Oncology
- Start
- Mar 2013
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vincristine, cisplatin, gemcitabine, pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Institute of Oncology. Started Mar 2013; status: completed.
02
Drugs
vincristinecisplatingemcitabinepemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2012-005504-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005504-17.